| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18780575 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 109 journal articles in the PubMed database | Email to a friend | | |
| Schwarz J, Korístek Z, Starý J, et al.
[Therapy of acute promyelocytic leukemia in Czechia: results and analysis of prognostic factors] [English Abstract, Journal Article]
Vnitr Lek 2008 Jul-Aug; 54(7-8):757-70.
Abstract | Full Citation | Find Related Articles | | Xin L, Wan-Jun S, Zeng-Jun L, et al.
A survival study and prognostic factors analysis on acute promyelocytic leukemia at a single center. [JOURNAL ARTICLE]
Leuk Res 2006 Sep 26.
Abstract | Full Citation | Find Related Articles | | Kanamaru A, Takemoto Y, Tanimoto M, et al.
All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Japan Adult Leukemia Study Group. [Clinical Trial, Journal Article, Multicenter Study]
Blood 1995 Mar 1; 85(5):1202-6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Tavernier E, Le QH, Elhamri M, et al.
Salvage therapy in refractory acute myeloid leukemia: prediction of outcome based on analysis of prognostic factors. [Journal Article]
Leuk Res 2003 Mar; 27(3):205-14.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Hu J, Shen ZX, Sun GL, et al.
Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and As2O3: an experience of 120 patients at a single institution. [Clinical Trial, Journal Article]
Int J Hematol 1999 Dec; 70(4):248-60.
Abstract | Full Citation | Find Related Articles | | Burnett AK, Grimwade D, Solomon E, et al.
Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: result of the Randomized MRC Trial. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Blood 1999 Jun 15; 93(12):4131-43.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Avvisati G, Lo Coco F, Diverio D, et al.
AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study. [Clinical Trial, Journal Article, Multicenter Study]
Blood 1996 Aug 15; 88(4):1390-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Fenaux P, Chastang C, Chevret S, et al.
A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Blood 1999 Aug 15; 94(4):1192-200.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Asou N, Adachi K, Tamura J, et al.
Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study Group. [Journal Article, Multicenter Study]
J Clin Oncol 1998 Jan; 16(1):78-85.
Abstract | Full Citation | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
